Angiopoietin-2 and biliary diseases: elevated serum, but not bile levels are associated with cholangiocarcinoma. by Torsten Voigtländer, Sascha David, Kristina Thamm, Jerome Schlué, Jochen Metzger, Michael P Manns, Tim O Lankisch

Get full text

Patients with primary sclerosing cholangitis require more sedation during endoscopic retrograde cholangiography by Carsten Keil, Lukas Aguirre Dávila, Theodor Framke, Henrike Lenzen, Michael P. Manns, Tim O. Lankisch, Torsten Voigtländer

Get full text

MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma. by Torsten Voigtländer, Shashi K Gupta, Sabrina Thum, Jasmin Fendrich, Michael P Manns, Tim O Lankisch, Thomas Thum

Get full text

Gilbert’s syndrome and antiviral therapy of hepatitis C by Katja Deterding, Kurt Grüngreiff, Tim O. Lankisch, Andrej Potthoff, Matthias J. Bahr, Michael P. Manns, Heiner Wedemeyer, Christian P. Strassburg

Get full text

Dilatation Therapy and Demographic Characteristics Significantly Influence the Amount of Propofol for Therapeutic Endoscopic Retrograde Cholangiography by Christoph A. Schmidt, Carsten Keil, Martha M. Kirstein, Frank Lehner, Michael P. Manns, Thomas von Hahn, Tim O. Lankisch, Torsten Voigtländer

Get full text

NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients by Christoph Jüngst, Vanessa Stadlbauer, Matthias C. Reichert, Vincent Zimmer, Susanne N. Weber, Lisa Ofner-Ziegenfuß, Torsten Voigtländer, Walter Spindelböck, Peter Fickert, Gabriele I. Kirchner, Frank Lammert, Tim O. Lankisch, Marcin Krawczyk

Get full text